NCNA Stock Analysis: Buy, Sell, or Hold?
NCNA - NuCana plc American Depositary Share
$1.35
0.03 (2.27%)
β²
5d:
+7.14%
30d:
-0.74%
90d:
-40.0%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 19, 2026
14d
Get Alerted When NCNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: NCNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
β BUY SIGNAL: NCNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: NCNA is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.26 to $1.43.
Technical Outlook: Technically, NCNA is in a downtrend. Immediate support is located at $1.21, while resistance sits at $1.41.
Market Sentiment: NCNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $104.00 (+7603.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NCNA is in a downtrend. Immediate support is located at $1.21, while resistance sits at $1.41.
Market Sentiment: NCNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $104.00 (+7603.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.26 -
$1.43
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 7603.7% below Wall St target ($104.00)
Trading Range Analysis
30-Day Trading Range
$1.26 -
$1.43
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.41
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.96
Wall Street Target
$104.00
(+7603.7%)
Share & Embed Analysis
Last updated: August 04, 2026 3:37 AM ET
Data refreshes hourly during market hours. Next update: 4:37 AM
Data refreshes hourly during market hours. Next update: 4:37 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NCNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical⦠|
STRONG BUY
17 analysts |
$86 | 47 HOLD |